gabexate has been researched along with Arteriosclerosis in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuzuya, F | 1 |
| Kuzuya, M | 1 |
| Yasue, M | 1 |
| Naito, M | 1 |
| Funaki, C | 1 |
| Hayashi, T | 1 |
| Asai, K | 1 |
1 other study available for gabexate and Arteriosclerosis
| Article | Year |
|---|---|
Clinical and experimental approaches to the prevention of atherosclerosis by immunological regulations.
Topics: Aged; Animals; Arteriosclerosis; Complement Activation; Complement System Proteins; Dextran Sulfate; | 1990 |